Skip to content
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • Sign-in
  • Subscribe

astrazenaca

AstraZeneca paying up to $2 billion for experimental obesity pill – as weight loss drug market grows

The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.

  • By Ty Roush
  • Forbes Staff
We use cookies to help us to deliver our services and provide personalised experiences. By using this website you agree to use our cookies. Cookie Policy

The best of Forbes, delivered to your inbox

I accept Forbes Australia's Terms and Privacy Policy

All set

Please check your inbox to confirm your subscription. Welcome to the Forbes community

 

  • Sections
    • News
    • Events
    • Lists
    • Life
  • Company
    • About us
    • Contact us
    • Careers
    • Advertise with us
    • Media
  • Explore
    • Billionaires
    • Entrepreneurs
    • Innovation
    • Leadership
Social
  • Facebook
  • LinkedIn
  • Instagram
  • Twitter
  • YouTube

Magazines covers

Get the magazine delivered with a Premium membership, find it at all good newsagents, or purchase previous issues online.

© 2025 Success Publishing Pty Ltd including content reproduced under license from Forbes IP (HK) LTD. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • Subscribe
  • Sign-in